Literature DB >> 20642073

Non-motor symptoms of Parkinson's disease: diagnosis and management.

F K Salawu1, A Danburam, A B Olokoba.   

Abstract

BACKGROUND: Non-motor symptoms (NMS) of Parkinson's disease (PD) are a key determinant of health, quality of life (QoL) and societal cost of PD. They are often less appreciated than motor symptoms but are important sources of disability for many PD patients.
METHODS: Literature search was performed using the reference databases Medline, Science Citation Index and EMBASE. The keywords used were 'non-motor symptoms', Parkinson's disease, olfaction and constipation. Papers discovered by this search were reviewed, as were references cited therein.
RESULTS: Contrary to common perception, many NMS of PD occur early in PD and some may even predate the diagnosis of PD that is based on motor signs. These include olfactory deficit, sleep problems such as rapid eye movement behaviour disorder, constipation and the more recently described male erectile dysfunction.
CONCLUSION: There is compelling evidence that non-motor symptoms of PD play a dominant role in the QoL and disability of PD patients and the QoL of their 'informal' carers. Effective clinical management of PD therefore demands that these symptoms be identified and to the extent possible treated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20642073     DOI: 10.4314/njm.v19i2.56496

Source DB:  PubMed          Journal:  Niger J Med        ISSN: 1115-2613


  16 in total

1.  The heterogeneity of non-motor symptoms of Parkinson's disease.

Authors:  Ning Zhang; Weiguo Liu; Min Ye; Alexander D Cohen; Yingdong Zhang
Journal:  Neurol Sci       Date:  2014-11-07       Impact factor: 3.307

2.  Combination of optical coherence tomography (OCT) and OCT angiography increases diagnostic efficacy of Parkinson's disease.

Authors:  Jing Zou; Kangcheng Liu; Fangling Li; Yi Xu; Lu Shen; Huizhuo Xu
Journal:  Quant Imaging Med Surg       Date:  2020-10

3.  Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease.

Authors:  Fardin Nabizadeh; Kasra Pirahesh; Elham Ramezannezhad
Journal:  Neurol Sci       Date:  2022-10-13       Impact factor: 3.830

4.  Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationale.

Authors:  David Charles; Christopher Tolleson; Thomas L Davis; Chandler E Gill; Anna L Molinari; Mark J Bliton; Michael G Tramontana; Ronald M Salomon; Chris Kao; Lily Wang; Peter Hedera; Fenna T Phibbs; Joseph S Neimat; Peter E Konrad
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

5.  Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis.

Authors:  Zhi-Li Ren; Chao-Dong Wang; Tao Wang; Hui Ding; Ming Zhou; Nan Yang; Yan-Yong Liu; Piu Chan
Journal:  Acta Pharmacol Sin       Date:  2018-07-10       Impact factor: 6.150

6.  Sleep spindle alterations in patients with Parkinson's disease.

Authors:  Julie A E Christensen; Miki Nikolic; Simon C Warby; Henriette Koch; Marielle Zoetmulder; Rune Frandsen; Keivan K Moghadam; Helge B D Sorensen; Emmanuel Mignot; Poul J Jennum
Journal:  Front Hum Neurosci       Date:  2015-05-01       Impact factor: 3.169

7.  Effects of L-arginine pre-treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's diseases in Balb/c mice.

Authors:  Javad Hami; Mehran Hosseini; Sekineh Shahi; Nassim Lotfi; Abolfazl Talebi; Mohammad Afshar
Journal:  Iran J Neurol       Date:  2015-10-07

Review 8.  Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.

Authors:  Fatemeh Nouri Emamzadeh
Journal:  J Mol Neurosci       Date:  2017-07-10       Impact factor: 3.444

9.  FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF.

Authors:  Guadalupe Vidal-Martínez; Javier Vargas-Medrano; Carolina Gil-Tommee; David Medina; Nathan T Garza; Barbara Yang; Ismael Segura-Ulate; Samantha J Dominguez; Ruth G Perez
Journal:  J Biol Chem       Date:  2016-08-15       Impact factor: 5.157

10.  Usefulness of Transcranial Magnetic Stimulation to Assess Motor Function in Patients With Parkinsonism.

Authors:  Jaechan Park; Won Hyuk Chang; Jin Whan Cho; Jinyoung Youn; Yun Kwan Kim; Sun Woong Kim; Yun-Hee Kim
Journal:  Ann Rehabil Med       Date:  2016-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.